β-Adrenoceptor agonists and asthma - 100 Years of development

European Journal of Pharmacology

Volumn 445, Issue 1-2, 2002, Pages 1-12

  Waldeck, Bertil ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Adrenaline; Asthma; Bronchodilation; Enantiomer; Adrenoceptor agonist

Indexed keywords

1 (3,4 DIHYDROXYPHENYL) 2 (3,3 DIPHENYL 1 METHYLPROPYL)AMINO 1 ETHANOL; 1 (4 HYDROXYPHENYL) 2 [3 (2 METHOXYPHENYL) 1,1 DIMETHYLPROPYLAMINO]ETHANOL; ADRENALIN; ALPHA ADRENERGIC RECEPTOR; ALPHA ETHYLADRENALINE; BAMBUTEROL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BROXATEROL; CARBUTEROL; CARMOTEROL; CLENBUTEROL; DICHLORISOPRENALINE; EPHEDRINE; FENOTEROL; FORMOTEROL; HEXOPRENALINE; ISOPRENALINE; ORCIPRENALINE; PIRBUTEROL; PROCATEROL; PROTOKYLOL; QH 25; S 1319; SALBUTAMOL; SALMETEROL; SOTERENOL; TERBUTALINE; TULOBUTEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ASTHMA; BRONCHODILATATION; BRONCHUS MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DRUG SELECTIVITY; ENANTIOMER; HUMAN; HYPERTENSION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; TREMOR;

EID: 0037036199     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01728-4     Document Type: Article

References (153)

1. A study of the adrenotropic receptors
2. Levalbuterol and racemic albuterol: Are there therapeutic differences?
3. 2-Agonists containing metabolically labile groups: I. The influence of ester groups in the nitrogen substituent
4. 2-Agonists containing metabolically labile groups. II. The influence of ester groups in the aryl system
5. ZK-90055
6. Some problems encountered in the evaluation of new bronchodilating β-adrenoceptor agonists
7. Why are long-acting beta-adrenoceptor agonists long-acting?
8. Relaxation kinetics of formoterol and salmeterol in the guinea-pig trachea in vitro
9. Selectivity of β-adrenoceptor agonists and antagonists on bronchial, skeletal, vascular and cardiac muscle in the anaesthtized cat
10. Stereochemistry, a basis for sofisticated nonsense in pharmacokinetics and clinical pharmacology
11. 2-adrenoceptors in the human myocardium
12. 2-adrenoceptor agonist: Characterization of pharmacological activity in vitro and in vivo
13. Chemical structure and sympathomimetic action of amines
14. Effect of beta-agonists on airway effector cells
15. Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues
16. Two new groups of selective stimulants of adrenergic β-receptors
17. Bronchodilators, N-substituted derivatives of 1-(3′,4′-dihydroxyphenyl)-2-aminoethanol (arterenol)
18. 2-adrenoceptor agonists for the treatment of airway diseases: 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues
19. Effects of adrenergic activators and inhibitors on the skeletal muscles
20. Actions of some sympathomimetic bronchodilator and beta-adrenoceptor blocking drugs on contractions of the cat soleus muscle
21. Actions of the sympathomimetic bronchodolator, rimiterol (R798), on the cardiovascular, respiratory and skeletal muscle systems of the anaesthetized cat
22. The effects of adrenaline, noradrenaline and isoprenaline on skeletal muscle contractions in the cat
23. 3-diol (AH 3365): A selective β-adrenergic stimulant
24. Some observations on the β-adrenoceptor agonist properties of the isomers of salbutamol
25. Sympahomimetic bronchodilator drugs
26. On the hypodermic use of adrenalin chloride in the treatment of asthmatic attacs
27. Comparative actions of sympathomimetic compounds: Bronchodilator actions in bronchial spasm induced by histamine
28. The action of ephedrine, the active principle of the Chinese drug Ma Huang
29. 2-adrenergic activity
30. Characterization of the adrenergic activity of carbuterol (SK&F 40383-A)
31. A comparative study of a new selective beta 2-adrenoceptor agonist, procaterol and salbutamol in asthma
32. Salbutamol: A new, selective β-adrenoceptive stimulant
33. Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs. evening administration
34. Effects of N-aralkyl substitution of β-agonists on α- and β-adrenoceptor subtypes: Pharmacological studies and binding assays
35. 2-adrenoceptor agonist salmeterol in guinea-pig trachea
36. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness
37. Pharmacologic potency and selectivity of a new bronchodilator agent: Soterenol (MJ 1992)
38. The four stereoisomers of a high potency congener of isoproterenol. Biological activity and the relationship between the native and the chemically inserted asymmetric carbon
39. 2-adrenergic agonists on body composition and protein synthesis in the rat
40. Struktur-Wirkungsbeziehungen in einer Reihe von neuen Amino-Halogen-substituierten Phenyl-aminoäthanolen
41. 2-Rezeptoren
42. Zur Pharmakologie des Sympathomimeticums 1-(3,5-dihydroxyphenyl)-1-hydroxy-2-isopropylaminoäthan
43. Clinical efficacy and safety of clenbuterol HCl when administered to effect in horses with chronic obstructive pulmonary disease (COPD)
44. Long duration and high potency of antiexudative effects of formoterol in guinea-pig tracheobronchial airways
45. Comparison of the anti-bronchoconstrictor activities of inhaled formoterol, its (R,R)- and (S,S)-enantiomers and salmeterol in the rhesus monkey
46. β-Adrenergic activity of soft drugs for the topical treatment of psoriasis
47. Present state of the controversy about regular inhaled β-agonists in asthma
48. Personalised medicine comes a step closer for asthma
49. Inhalation therapy of bronchial asthma
50. Sustained activation of a G protein-coupled receptor via "anchored" agonist binding
51. Pharmacologische Untersuchungen der neuen Substanz Reproterol mit bronchospasmolytischer Wirkung aus der Substanzklasse der β-Phenyläthyl-aminoalkyl-xanthine
52. Sympathomimetic enantiomers and asthma
53. Absolute configuration of the optical isomers of salbutamol
54. Adrenaline and related compounds: Influence of structure on physiological activity
55. On the possible role of potassium ions in the action of terbutaline on skeletal muscle contractions
56. Comparison of the action of BD 40A and some other β-adrenoceptor stimulants on the isolated trachea and atria of the guinea pig
57. Cardiorespiratory activities of 3-formylamino-4-hydroxy-α- (N-1-methyl-2-p-methoxyphenethylaminomethyl)-benzylalcohol-hemifumarate (BD 40A) and some other β-adrenoceptor stimulants in conscious guinea pigs
58. Pharmacological studies of trans-6-hydroxy-5-hydroxymethyl-2-isopropylamino-1,2,3,4-tetrahydro-1- naphtalenol hydrochloride (AA 497), a new potent bronchodilator
59. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols
60. Conjugates of catecholamines: 1. N-Alkyl-functionalized carboxylic acid congeners and amides related to isoproterenol
61. Steric aspects of agonism and antagonism at β-adrenoceptors: Experiments with the enantiomers of terbutaline and pindolol
62. On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration
63. Formoterol and salmeterol are both long acting compared to terbutaline in the isolated perfused and ventilated guinea-pig lung
64. Salmeterol
65. 2-Adrenoceptors in guinea-pig atria
66. 2-adrenoceptor selectivity in three series of β-adrenoceptor agonists
67. Zur Physiologie der Trachea
68. Adrenergic agents: 3. Synthesis and adrenergic activity of some catecholamine analogs bearing a substituted sulfonyl or sulfonylalkyl group in the meta position
69. 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro
70. 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea-pig tissues
71. 2-agonist therapy in asthma
72. Neue broncholytisch hochwirksame Körper der Adrenalinreihe
73. Zur Pharmakologie neuer adrenalinverwandter Körper
74. On the discovery of isoprenaline
75. Pharmacological studies of 1-(o-chlorophenyl)-2-tert-butylaminoethanol (C-78)
76. A comparision of the cardiac stimulating and bronchodilator actions of selected sympathomimetic amines
77. The effect of changes in molecular configuration on inhibitory sympathomimetic action
78. The pharmacologic action of some analogs of 1-(3,4-dihydroxyphenyl)-2-amino-1-butanol (ethylnorepinephrine)
79. Differentiation of receptor systems activated by sympathomimetic amines
80. Differentiation of receptors responsive to isoproterenol
81. 2-adrenergic bronchodilator 3-(4-methoxybenzylamino)-4-hydroxy-α-(tert-butylaminomethyl)-benzyl- alcohol, HCl (QH25)
82. 2 agonist in humans
83. 2-adrenergic receptor, focus on interaction of agonist with receptor
84. Salmeterol, formoterol, and salbutamol in the isolated guinea-pig trachea: Differences in maximum relaxant effect and potency but not in functional antagonism
85. Metabolism of bambuterol in rat livermicrosomes: Identification of hydroxylated and demethylated products by liquid chromatography mass spectrometry
86. 2-adrenoceptor agonist - D2343 - With long duration
87. 2-adrenergic agonist
88. 2-adrenoceptor agonists, D2343 and QH25, studied in asthmatic patients
89. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients
90. Comparison of the effects of (-)-isoprenaline, orciprenaline, terbutaline, and Me506 on heart rate, soleus muscle contractility and pulmonary resistance of anaesthetized cats
91. Bronchodilators giving reduced cardiovascular effects. Relative biological activities of the four isomers of 1-(3,4-dihydroxyphenyl)-2-isopropylaminobutanol
92. Peripheral β-adrenergic receptors concerned with tremor
93. Food poisoning related to consumption of illicit β-agonist in liver
94. The effect of orciprenaline and its p-hydroxyphenyl derivative on the peak expiratory flow rate in asthmatic patients
95. This and that: Neither epinephrine nor adrenaline
96. 2-selective sympathomimetics
97. Studies on bitolterol, di-p-toluate ester of N-tert-butylarterenol: A new long-acting bronchodilator with reduced cardiovascular effects
98. 2 adrenoceptor agonists: Interactions in human contracted bronchi
99. 2 adrenergic bronchodilator
100. 2-adrenoceptor agonists for the modulation of sensory nerves in COPD
101. 2-adrenoceptor agonist salmeterol
102. Formoterol on airway smooth muscle and human lung mast cells: A comparison with salbutamol and salmeterol
103. Salmeterol versus formoterol in patients with moderately severe asthma: Onset and duration of action
104. 2 -adrenoceptor-stimulating drugs
105. A selective β-adrenoceptor stimulant (Th1165a) related to orciprenaline
106. New lipophilic terbutaline ester prodrugs with long effect duration
107. Effects of β-adrenoceptor agonists on airway smooth muscle and on slow-contracting skeletal muscle. In vitro and in vivo results compared
108. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: Onset of action, duration of effect and potency
109. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients
110. Steric aspects of adrenergic drugs
111. Effect of inhaled formoterol and budesonide on exacerbations of asthma
112. The research behind terbutaline
113. Some pharmacological properties of terbutaline (INN), 1-(3,5-dihydroxyphenyl)-2-(t-butylamino)-ethanol, a new sympathomimetic β-receptor-stimulating agent
114. Blocking of inhibitory adrenergic receptors by a dichloro analog of isoproterenol
115. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours i bronchial asthma
116. Conjugates of catecholamines. II. In vitro and in vivo pharmacological activity of N-alkyl-functionalized carboxylic acid congeners and amides related to isoproterenol
117. Conjugates of catecholamines: IV. In vitro and in vivo pharmacological activity of monodisperse oligopeptide conjugates
118. 2 adrenoceptors in mammalian lung: Evidence from direct binding studies
119. Airway hyperreactivity
120. Über Oxy-Ephedrine
121. Ein neues Isoprenalin-Derivat (1-(3,5-Dihydroxyphenyl)-1-hydroxy-2-[1-(4-hydroxyphenyl)-isopropyl]- aminoaethan, Th 1165 a) in der Therapie akuter cardiovasculärer und respiratorischer Notfallsituationen
122. Regular inhaled beta-agonists treatment in bronchial asthma
123. Comparison of salmefamol and salbutamol in patients with chronic airway obstruction
124. Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma
125. Carbostyril-based beta-adrenergic agonists: Evidence for long lasting or apparent irreversible receptor binding and activation of adenylate cyclase activity in vitro
126. Die stimulierende Wirksamkeit von Hexoprenalin auf verschiedene sympathische β-Rezeptoren
127. 2-adrenoceptor agonist from a marine sponge Dysidea sp.
128. 2-adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues
129. 2-adrenoceptor agonist, on IgE-mediated activation of human cultured mast cells
130. Comparative actions of sympathomimetic compounds: Bronchodilator actions in perfused guinea-pig lungs
131. 2-receptor stimulant
132. 2 sympathomimetics in isolated receptor membranes: Evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase
133. 2-sympathomimetics contribute to their relaxant effect in airway smooth muscle cells
134. Comparison of infused and inhaled terbutaline in patients with asthma
135. Modification by reserpine of the response of the atrial pacemaker to sympathomimetic amies
136. Steric aspects of agonism and antagonism at β-adrenoceptors: Synthesis of and pharmacological experiments with the enantiomers of formoterol and their diastereomers
137. 2 adrenoceptor agonist: Comparison with salbutamol in adult asthmatic patients
138. 2-adrenoceptor agonist, TA-2005
139. An in vitro method for the study of β-receptor mediated effects on slow contracting skeletal muscle
140. Biological significance of the enantiomeric purity of drugs
141. Some pharmacodynamic aspects on long-acting β-adrenoceptor agonists
142. 2-adrenoceptor agonists: Is there a cause for concern?
143. The interaction of ephedrine with β-adrenoceptors in tracheal, cardiac and skeletal muscles
144. Partial agonism and functional selectivity: A study on β-adrenoceptor mediated effects in tracheal, cardiac and skeletal muscle
145. Norepinephrine, adrenaline, and the sympathomimetic amines
146. Resolution of terbutaline, a new β-sympathomimetic amine
147. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose off inhaled steroids
148. The β-adrenoceptor stimulant properties of OPC-2009 on guinea-pig isolated tracheal, right atrial and left atrial preparations
149. Pharmacological studies of OPC-2009, a newly synthesized selective beta adrenoceptor stimulant, in the bronchomotor and cardiovascular system of the anesthetized dog
150. Isomers of erythro-5-(1-hydroxy-2-iopropylaminobutyl)-8-hydroxycarbostyril, a new bronchodilator